Default: Bioorganic and Medicinal Chemistry Letters

ISSN: 0960-894X

Journal Home

Journal Guideline

Bioorganic and Medicinal Chemistry Letters Q2 Unclaimed

Elsevier Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bioorganic and Medicinal Chemistry Letters is a journal indexed in SJR in Molecular Biology and Biochemistry with an H index of 147. It has an SJR impact factor of 0,617 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,617.

Bioorganic and Medicinal Chemistry Letters focuses its scope in these topics and keywords: inhibitors, potent, derivatives, receptor, synthesis, evaluation, activity, selective, protein, d, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Metrics

Bioorganic and Medicinal Chemistry Letters

0,617

SJR Impact factor

147

H Index

657

Total Docs (Last Year)

2293

Total Docs (3 years)

20184

Total Refs

6212

Total Cites (3 years)

2292

Citable Docs (3 years)

2,65

Cites/Doc (2 years)

30,72

Ref/Doc

Aims and Scope


inhibitors, potent, derivatives, receptor, synthesis, evaluation, activity, selective, protein, d, kinase, biological, based, human, part, relationship, series, relationships, analogs, discovery, tyrosine, potential, sar, type,



Best articles by citations

Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V

View more

Nonbenzamidine compounds as selective factor xa inhibitors

View more

A QSAR study investigating the effect of l-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T

View more

Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L

View more

Enzymatic synthesis of (6R)- and (6S)-fluoroshikimic acids

View more

Corrigendum to "First pharmacophoric hypothesis for 5-HT7 antagonism"

View more

The binding of cocaine to cyclodextrins

View more

Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside

View more

A Unique Ring-Expanded Acyclic Nucleoside Analogue that Inhibits Both Adenosine Deaminase (ADA) and Guanine Deaminase (GDA; Guanase): Synthesis and Enzyme Inhibition Studies of 4,6-Diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine

View more

The Synthesis and Selective IL-2 Inhibitory Activity of Bis Piperazine-Phenol Mannich Adducts

View more

Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries

View more

Cellular solid-phase binding assay and mass spectrometry for screening of a4beta7 integrin antagonists

View more
SHOW MORE ARTICLES

Mechanistic studies on prolyl-4-hydroxylase: the vitamin c requiring uncoupled oxidation

View more

Synthesis of a water-soluble prodrug of entacapone

View more

Design and synthesis of a conformationally constrained analog of the bis(heteroaryl)piperazine (BHAP) HIV-1 reverse transcriptase inhibitor atevirdine

View more

Design and synthesis of a novel class of histone deacetylase inhibitors

View more

The Synthesis of 4-Arylsulfanyl-substituted Kainoid Analogues from trans-4-Hydroxy-l-proline

View more

Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands

View more

Stereo-random synthesis of highly functionalized proline analogues by azomethine cycloaddition

View more

Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT

View more

Win 70197: a novel liver-targeted magnetic resonance imaging contrast agent

View more

Polyhydroxylated 3-(N-phenyl) carbamoyl-2-iminochromene derivatives as potent inhibitors of tyrosine kinase p60c-src

View more

Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes

View more

Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1

View more

Comments

No comments ... Be the first to comment!

FAQS